How many employees does Genedrive have this year?
Genedrive has 46 undefined employees this year.
Genedrive Employees 2024
Genedrive Employees
46
Ticker
GDR.L
ISIN
GB00B1VKB244
WKN
A0ML2T
In 2024, Genedrive employed 46 people, a 0% change from the 46 number of employees in the previous year.
Genedrive Aktienanalyse
What does Genedrive do?
Genedrive PLC is a biomedical company based in Manchester, United Kingdom, specializing in the development of innovative diagnostic tests for infectious diseases and cancer. The company was founded in 2007 under the name Epistem Limited and went public in 2013. The business model of Genedrive involves developing and distributing innovative molecular diagnostic tests for diseases worldwide. The company's main goal is to change the way infectious diseases and cancer are diagnosed and treated by offering rapid, accurate, and cost-effective tests. The company has two main divisions: Genprobe and Instruments. Under Genprobe, various in vitro diagnostic tests for infectious diseases and diseases of the human immune system, including tuberculosis, hepatitis C, hepatitis B, HIV, and others, are offered. Under Instruments, Genedrive offers PCR instruments used for analyzing samples for DNA and RNA sequences. Some of Genedrive's key products include: - Genedrive HCV-ID Testkit: A test kit for identifying and quantifying hepatitis C viruses (HCV) in human blood samples. The test provides results within 90 minutes and has high accuracy. - Genedrive MT-RNR1 Testkit: A test kit for the rapid diagnosis of tuberculosis (TB), one of the most common infectious diseases worldwide. The test utilizes PCR technology and provides results within 90 minutes. - Genedrive Genedrive 96: An instrument for simultaneous analysis of up to 96 PCR samples. The system offers high accuracy and precision in analyzing RNA and DNA sequences. The company collaborates closely with leading research institutions and health organizations worldwide to improve its products and develop new tests. Genedrive has formed partnerships with the British government, the US Department of Defense, and other institutions. In recent years, the company has made significant progress in developing new diagnostic tests for infectious diseases and cancer. For example, Genedrive recently signed an agreement with the Foundation for Innovative New Diagnostics (FIND) to develop a molecular test for the Ebola virus. The company also has a pipeline of projects, including tests for COVID-19 and antibiotic resistance. Despite Genedrive's success, the company remains committed to innovation and research in order to transform the diagnostics industry and improve the health of people worldwide. Genedrive is expected to continue playing an important role in the fight against infectious diseases and cancer in the future. Genedrive ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining Genedrive's Employee Base
Genedrive's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Genedrive's operational capacity and future potential.
Year-to-Year Comparison
Assessing Genedrive's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
Genedrive's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in Genedrive’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about Genedrive stock
How many employees did Genedrive have compared to the previous year?
Compared to the previous year, Genedrive had 0% more employees.
What impact did the number of employees have on the company Genedrive?
The number of employees has a direct impact on the efficiency and productivity of Genedrive. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of Genedrive?
The number of employees can also have an impact on investors of Genedrive, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of Genedrive affect the company?
An increase in equity of Genedrive can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in Genedrive's equity affect the company?
A reduction in equity of Genedrive can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of Genedrive?
Some factors that can influence the equity of Genedrive include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of Genedrive so important for investors?
The equity of Genedrive is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at Genedrive influence the company?
The number of employees at Genedrive can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at Genedrive evolved in recent years?
In recent years, the number of employees at Genedrive has changed by 0.
How many employees does Genedrive currently have?
Genedrive currently has 46 undefined employees.
Why is the number of employees important for investors of Genedrive?
The number of employees is important for investors of Genedrive as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can Genedrive take to change the number of employees?
To change the number of employees, Genedrive can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does Genedrive pay?
Over the past 12 months, Genedrive paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genedrive is expected to pay a dividend of 0 GBP.
What is the dividend yield of Genedrive?
The current dividend yield of Genedrive is .
When does Genedrive pay dividends?
Genedrive pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Genedrive?
Genedrive paid dividends every year for the past 0 years.
What is the dividend of Genedrive?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is Genedrive located?
Genedrive is assigned to the 'Health' sector.
Wann musste ich die Aktien von Genedrive kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Genedrive from 9/17/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.
When did Genedrive pay the last dividend?
The last dividend was paid out on 9/17/2024.
What was the dividend of Genedrive in the year 2023?
In the year 2023, Genedrive distributed 0 GBP as dividends.
In which currency does Genedrive pay out the dividend?
The dividends of Genedrive are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Genedrive
Our stock analysis for Genedrive Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genedrive Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
